Nurix Therapeutics, Inc. (NRIX): Depreciation & Amortization
$8.74M
Year ended 2025-11-30
$8.60M
Trailing 12 months to 2026-05-31
+17.8%
3-year compound annual growth
+32.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | $8.74M | -6.2% | 2026-01-28, From 2024-12-01 |
| 2024-11-30 | $9.32M | +23.7% | 2026-01-28, From 2023-12-01 |
| 2023-11-30 | $7.53M | +40.8% | 2026-01-28, From 2022-12-01 |
| 2022-11-30 | $5.35M | +91.7% | 2025-01-28, From 2021-12-01 |
| 2021-11-30 | $2.79M | +28.0% | 2023-02-09, From 2020-12-01 |
| 2020-11-30 | $2.18M | -7.4% | 2022-01-28, From 2019-12-01 |
| 2019-11-30 | $2.35M | n/a | 2022-01-28, From 2018-12-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $8.74M | -6.2% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $1.37M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $9.26M | -26.0% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $10.12M | +6.2% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $562.6K | +4.5% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
Compare NRIX, SPRY, LAB, ARCT side by side · Screen every company in Pharmaceutical Preparations ↗